Cardax Reports Q2 2020 Results

Author's Avatar
Aug 15, 2020
Article's Main Image

- Operating loss decreased vs. Q2 2019

- Net loss increased vs. Q2 2019

- ZanthoSyn® revenues increased vs. Q2 2019

- Cardax submits invited federal grant application for COVID-19 clinical trial

PR Newswire